Christophe Couturier
Corporate Officer/Principal at AVANTOR, INC.
Net worth: 2 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Stubblefield | M | 51 | 10 years | |
| Claudius Sokenu | M | - | - | |
| Jonathan Peacock | M | 66 | 7 years | |
| Jürgen Glaser | M | 61 | 12 years | |
| John Carethers | M | 60 | 3 years | |
| Mala Murthy | M | 60 | 3 years | |
| James Bramwell | M | 57 | 7 years | |
| Lan Kang | F | 55 | 3 years | |
| Gregory Summe | M | 68 | 4 years | |
| Joseph Massaro | M | 54 | 3 years | |
| Michael Severino | M | 58 | 4 years | |
| Juan Andres | M | 59 | 5 years | |
| Marcus Kuhnert | M | 56 | 10 years | |
| Helga Rübsamen-Schaeff | M | 75 | 10 years | |
| R. Jones | M | 54 | 1 years | |
| Allison Hosak | F | - | - | |
| Steven Eck | M | 48 | 5 years | |
| Michael Wondrasch | M | 55 | 6 years | |
| Kitty Sahin | F | - | 2 years | |
| Ruediger Weseloh | M | - | 18 years | |
| Ilja Doering | M | - | 14 years | |
| Christina Jones | F | - | - | |
| Brittany Hankamer | F | - | 1 years | |
| Benoit Gourdier | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harald F. Stock | M | 56 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Chris Kroeger | M | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Maria Rivas | M | 60 | 2 years | |
| Philip Lee | M | 43 | 4 years | |
| David Sinclair | M | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 6 years |
| Thomas Malley | M | 55 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 5 years |
| Markus Bamberger | M | 58 | 5 years | |
| Stefan Oschmann | M | 66 | 10 years | |
| Bernhard R. M. Ehmer | M | 69 | 20 years | |
| Wolfgang Heinz Büchele | M | 64 | 15 years | |
| Friederike Rotsch | M | 51 | 18 years | |
| Karl-Ludwig Kley | M | 72 | 10 years | |
| Rehan Verjee | M | 43 | 6 years | |
| Rick Ryan | M | - | 11 years | |
| Thomas Kessler | M | 59 | - | |
| Lynne Sullivan | F | 58 | 8 years | |
| Malte Peters | M | 61 | 1 years | |
| Karen Long | F | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Ana María Rubio | F | 52 | 5 years | |
| Isabel de Paoli | F | 50 | 15 years | |
| Toni Spinazzola | F | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Walter Galinat | M | 68 | - | |
| Michel Cimon | M | - | 4 years | |
| Jörg Hornstein | M | 47 | 11 years | |
| David Smoller | M | 60 | 2 years | |
| Robert Paccasassi | M | 55 | 3 years | |
| Thomas Ulmer | M | 45 | 4 years | |
| Kostas Kaloulis | M | - | 6 years | |
| Daniya Malik | F | 34 | 1 years | |
| Amelie Schrader | F | - | 6 years | |
| Natalia Novac | F | - | 4 years | |
| Tatyana Staneva | F | - | 8 years | |
| Inderpal Singh | M | 58 | 2 years | |
| David Gaiero | M | 45 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 2 years |
| Jonathan Freeman | M | 56 | 8 years | |
| Rajkumar Kannan | M | 61 | 9 years | |
| Bjorn Hofman | M | 54 | 1 years | |
| Maya Martinez-Davis | F | 54 | 3 years | |
| Andrew Schiermeier | M | 54 | 3 years | |
| Megan Wherry Menner | F | - | 4 years | |
| David St. Denis | M | - | - | |
| Mark Shearman | M | 62 | 6 years | |
| Siegfried Karjetta | M | 69 | 5 years | |
| Bradley David Simpson | M | 49 | 4 years | |
| Johannes Baillou | M | 59 | 6 years | |
| Bernhard Scheuble | M | 71 | - | |
| Jean-Paul Mangeolle | M | 62 | 2 years | |
| Arend Oetker | M | - | - | |
| Irwin Scher | M | 84 | 3 years | |
| David S. McCullough | M | 59 | 5 years | |
| Lothar H. Finke | M | - | 9 years | |
| Hans-Jürgen Leuchs | M | 74 | 5 years | |
| Jeffrey E. Young | M | 51 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 2 years |
| Rolf Krebs | M | 84 | 8 years | |
| Marek Dziki | M | 61 | 1 years | |
| Olaf Klinger | M | 59 | 4 years | |
| Michael Roemer | M | - | - | |
| Matthias Zachert | M | 56 | 3 years | |
| Dorothea Wenzel | M | 55 | 17 years | |
| Frank Binder | M | 64 | 6 years | |
| Laszlo Radvanyi | M | 63 | - | |
| Albrecht Merck | M | 74 | 14 years | |
| Michael Becker | M | 76 | 13 years | |
| Gregor Schulz | M | 74 | 5 years | |
| Wayne Paterson | M | 56 | 8 years | |
| Nigel Williams | M | - | 11 years | |
| Allene Diaz | F | 59 | - | |
| Joachim Christ | M | 59 | - | |
| James Stewart | M | 63 | - | |
| Inge Lues | M | - | - | |
| Nilesh Kumar | M | 47 | - | |
| Frederic Wohlwend | M | - | - | |
| Ton Adang | M | 63 | 1 years | |
| Tobias Thelen | M | 48 | 5 years | |
| Paris Panayiotopoulos | M | 50 | 1 years | |
| Zaborowski MaryJo | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 73 | 73.00% |
| United States | 27 | 27.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christophe Couturier
- Personal Network
